Clinical Trial Update: Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating surgery with or without radiofrequency ablation followed by irinotecan for colorectal cancer with liver metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camptosar (irinotecan)

Snippet

Sponsor: University of Washington | Conditions: Colorectal Cancer, Metastatic Cancer | Phase 2 | Status: COMPLETED